GLP-1 use in US kids under-12 soars

Use of GLP-1 drugs among US children aged 8-11 has increased dramatically since 2019 despite a lack of FDA approval for this age group, as childhood obesity rates remain high with one in five American children affected.

This Wire brief sits within Fusion42's coverage of Health, and 2 sources have reported it.